IL-1RN+2018T>C polymorphism is correlated with colorectal cancer

被引:18
作者
Burada, Florin [1 ,2 ]
Dumitrescu, Theodor [3 ]
Nicoli, Raluca [1 ,2 ]
Ciurea, Marius Eugen [1 ,2 ]
Angelescu, Cristina [1 ,2 ]
Mixich, Francisc [1 ,2 ]
Ioana, Mihai [1 ,2 ]
机构
[1] Univ Med & Pharm Craiova, Res Ctr Gastroenterol & Hepatol, Craiova, Romania
[2] Univ Med & Pharm Craiova, Human Genom Lab, Craiova, Romania
[3] Univ Med & Pharm Craiova, Dept Surg, Craiova 200349, Romania
关键词
Colorectal cancer; Inflammation; Interleukin-1; Cytokines; Polymorphism; INTERLEUKIN-1 RECEPTOR ANTAGONIST; CYTOKINE GENE POLYMORPHISMS; COLON-CANCER; PROINFLAMMATORY CYTOKINES; COMMON POLYMORPHISMS; INFLAMMATION; IL-1-BETA; SURVIVAL; DISEASE; RISK;
D O I
10.1007/s11033-012-2300-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epidemiological and experimental evidence indicates chronic inflammation as a risk factor for colorectal cancer. We investigated whether IL-1B -511C > T (rs16944), IL-1B +3954C > T (rs1143634) and IL1-RN +2018T > C (rs419598) cytokine polymorphisms are correlated with colorectal cancer. Blood samples were obtained from 377 Romanian subjects: 144 patients with sporadic colorectal cancer and 233 healthy controls. Polymorphisms were analyzed by allelic discrimination TaqMan PCR assays with specific probes. The results of our study showed that IL-1RN +2018T > C polymorphism is associated with colorectal cancer. We found that there was a significant difference in the frequency of CC genotype between patients with colorectal cancer and the control group (OR 2.42, 95 % CI: 1.06-5.53, p = 0,034) when TT genotype was used as reference. Furthermore, in a stratified analysis, a positive association was found only for IL-1RN +2018CC genotype, that was limited to early I and II stages (OR 2.72, 95 % CI: 1.05-7.03, p = 0,033). We did not find any association between any of the IL-1B polymorphisms and colorectal cancer. In conclusion this study found that IL-1RN +2018T > C polymorphism is associated with colorectal cancer, mainly for localized disease.
引用
收藏
页码:2851 / 2857
页数:7
相关论文
共 42 条
[1]   Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1β [J].
Akagi, Y ;
Liu, W ;
Xie, K ;
Zebrowski, B ;
Shaheen, RM ;
Ellis, LM .
BRITISH JOURNAL OF CANCER, 1999, 80 (10) :1506-1511
[2]   Interleukin-1 receptor antagonist: Role in biology [J].
Arend, WP ;
Malyak, M ;
Guthridge, CJ ;
Gabay, C .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :27-55
[3]   A polymorphism of the interleukin-1β gene influences survival in pancreatic cancer [J].
Barber, MD ;
Powell, JJ ;
Lynch, SF ;
Fearon, KCH ;
Ross, JA .
BRITISH JOURNAL OF CANCER, 2000, 83 (11) :1443-1447
[4]  
Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO
[5]  
2-Z
[6]   Recent trends in colorectal cancer mortality in Europe [J].
Bosetti, Cristina ;
Levi, Fabio ;
Rosato, Valentina ;
Bertuccio, Paola ;
Lucchini, Franca ;
Negri, Eva ;
La Vecchia, Carlo .
INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (01) :180-191
[7]   Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression [J].
Cacev, Tamara ;
Radosevic, Senka ;
Krizanac, Simun ;
Kapitanovic, Sanja .
CARCINOGENESIS, 2008, 29 (08) :1572-1580
[8]   Inflammation and cancer [J].
Coussens, LM ;
Werb, Z .
NATURE, 2002, 420 (6917) :860-867
[9]   Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST) [J].
Crusius, J. B. A. ;
Canzian, F. ;
Capella, G. ;
Pena, A. S. ;
Pera, G. ;
Sala, N. ;
Agudo, A. ;
Rico, F. ;
Del Giudice, G. ;
Palli, D. ;
Plebani, M. ;
Boeing, H. ;
Bueno-de-Mesquita, H. B. ;
Carneiro, F. ;
Pala, V. ;
Save, V. E. ;
Vineis, P. ;
Tumino, R. ;
Panico, S. ;
Berglund, G. ;
Manjer, J. ;
Stenling, R. ;
Hallmans, G. ;
Martinez, C. ;
Dorronsoro, M. ;
Barricarte, A. ;
Navarro, C. ;
Quiros, J. R. ;
Allen, N. ;
Key, T. J. ;
Binghan, S. ;
Caldas, C. ;
Linseisen, J. ;
Kaaks, R. ;
Overvad, K. ;
Tjonneland, A. ;
Buechner, F. C. ;
Peeters, P. H. M. ;
Numans, M. E. ;
Clavel-Chapelon, F. ;
Trichopoulou, A. ;
Lund, E. ;
Jenab, M. ;
Rinaldi, S. ;
Ferrari, P. ;
Riboli, E. ;
Gonzalez, C. A. .
ANNALS OF ONCOLOGY, 2008, 19 (11) :1894-1902
[10]   Elevated tumour interleukin-1β is associated with systemic inflammation:: a marker of reduced survival in gastro-oesophageal cancer [J].
Deans, D. A. C. ;
Wigmore, S. J. ;
Gilmour, H. ;
Paterson-Brown, S. ;
Ross, J. A. ;
Fearon, K. C. H. .
BRITISH JOURNAL OF CANCER, 2006, 95 (11) :1568-1575